Medical Device Industry News

  • Intuitive Surgical Seeks a Rosier 2015

    Intuitive Surgical executives think more international expansion and continued innovation of its new da Vinci Xi system will help the Sunnyvale, CA–based surgical robots company move past a mixed and volatile 2014. For the final three months of 2014, Intuitive saw profits of $147 million, or $3.94 per share. Profits were up 8% from the previous quarter’s $123.7 million, or $3.35 per share. But year-over-year, they were down 6% to $419 million. (They did, however, beat analysts’ expectations, according to media reports.)

  • J&J Device Sales Down Nearly 8% in U.S.

    Alex Gorsky Johnson & Johnson’s fourth-quarter medical device sales fell by 4.7%, to $6.6 billion, with the biggest drop (7.7%) in the U.S., the company announced this week.

  • Getinge Woes Continue as CEO Resigns

  • FDA Says Many Wearables Won't Need Their Approval

    Just in time for the next wave of wearable wellness devices appears ready to roll, FDA has issued guidance statements about wellness products and medtech accessories.One guidance document defines general wellness products as:

  • Why the Carmat Artificial Heart Could Be a Big Deal

    The second patient implanted with a Carmat artificial heart has gone home, opening the way for others enrolled in the French company’s clinical trial to receive the devices.

  • Google Glass: Dead or Undead?

    Google Glass freaked out some regular folks who feared for their privacy. Many were unsure about the practical applications for a wearable Android computer with an optical head-mounted display.Others were simply baffled at the price of admission ($1500) to the Google Glass inner circle of “Explorers.” When the company announced this week on Google+ that its wearable device had “graduated” from the Google[x] laboratories, and would not be sold after Jan. 19, some thought Google Glass was dead.

  • 'Pacemaker for the Stomach' Wins FDA Nod

    The EnterMedics Maestro Rechargeable System weight loss treatment device is effective although scientists are unclear why. The FDA has approved the first weight-loss device since 2007, giving obese adults an alternative to dieting and bariatric surgery.

  • Antitrust Accusations Levied at Leading Hospital Bed Maker

    Hill-Rom—the dominant player in the U.S. hospital bed market—is facing a federal lawsuit in western Texas that alleges that the company has used its position to squeeze out competitors in the hospital rental market.

  • Stryker, St. Jude Medical Have a Dollar Problem: Is It Also Your Problem?

    As the U.S. dollar strengthens amid global economic uncertainty, travelers aren’t the only ones affected. Major medtech companies including St. Jude Medical and Stryker are feeling the pinch, too. St. Jude Medical on Wednesday reported that the impact of foreign currency held down sales growth in the fourth quarter ended January 3. The Little Canada, MN–based says sales for the quarter were up 1% year-over-year, to $1.44 billion, but it would have been a 5% growth if currency didn’t have an effect.

  • Oracle and Proteus Team Up to Reinvent Clinical Trials

    Proteus Digital Health has teamed up with Oracle to monitor clinical trials. Nearly half of all Phase III pharmaceutical clinical trials fail, partly because data about patient adherence is hard to come by.